European Commission chief Ursula von der Leyen announced on Friday that AstraZeneca-Oxford University’s coronavirus vaccine had been approved for the EU market hours after the block’s drug agency recommended its approval.
It is the third vaccine approved for use in the EU of 27 countries after competitive shots from Pfizer-BioNTech and Moderna.
“I expect the company to deliver the agreed 400 million cans,” tweeted von der Leyen as the dispute between Brussels and AstraZeneca intensified.
“We will continue to do everything we can to secure vaccines for Europeans, our neighbors and partners around the world.”
The British-Swedish company has admitted that production problems mean that it can only deliver a fraction of the doses promised to the EU in the short term.
This is a major blow to Europe’s already difficult rollout efforts as the EU is put on a collision course with former member Britain as they battle over AstraZeneca’s limited supplies.
AstraZeneca’s approval of the vaccine is also amid controversy over the sting within the EU.
The German Vaccine Commission said Thursday that the vaccine should not be used in people over 65 due to insufficient evidence of its effectiveness.
Even after the European Medicines Agency (EMA) recommended that the AstraZeneca shot be allowed for all age groups on Friday, the German panel maintained its position.
(This story was not edited by GossipMantri staff and is automatically generated from a syndicated feed.)